[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE457992T1 - Platinkomplexe und deren verwendung in der therapie - Google Patents

Platinkomplexe und deren verwendung in der therapie

Info

Publication number
ATE457992T1
ATE457992T1 AT02760540T AT02760540T ATE457992T1 AT E457992 T1 ATE457992 T1 AT E457992T1 AT 02760540 T AT02760540 T AT 02760540T AT 02760540 T AT02760540 T AT 02760540T AT E457992 T1 ATE457992 T1 AT E457992T1
Authority
AT
Austria
Prior art keywords
platinum complexes
therapy
present
concerns novel
novel platinum
Prior art date
Application number
AT02760540T
Other languages
English (en)
Inventor
Yechezkel Barenholz
Dan Gibson
Yousef Najajreh
Elena Khazanov
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE457992T1 publication Critical patent/ATE457992T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT02760540T 2001-08-23 2002-08-21 Platinkomplexe und deren verwendung in der therapie ATE457992T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411501P 2001-08-23 2001-08-23
PCT/IL2002/000687 WO2003017998A1 (en) 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment

Publications (1)

Publication Number Publication Date
ATE457992T1 true ATE457992T1 (de) 2010-03-15

Family

ID=23218625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760540T ATE457992T1 (de) 2001-08-23 2002-08-21 Platinkomplexe und deren verwendung in der therapie

Country Status (9)

Country Link
US (1) US7122668B2 (de)
EP (1) EP1420775B1 (de)
JP (1) JP2005501859A (de)
AT (1) ATE457992T1 (de)
CA (1) CA2456348A1 (de)
DE (1) DE60235375D1 (de)
ES (1) ES2339228T3 (de)
IL (1) IL159993A0 (de)
WO (1) WO2003017998A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
JP5107573B2 (ja) 2003-04-25 2012-12-26 ザ ペン ステイト リサーチ ファウンデーション 増殖抑制性脂質由来生物活性化合物の全身送達方法およびシステム
JP2007512318A (ja) * 2003-11-25 2007-05-17 プラトコ・テクノロジーズ・（プロプライエタリー）・リミテッド 白金（ｉｉ）錯体並びに該錯体の製法及び使用
MX2007002453A (es) 2004-09-01 2007-05-04 Platco Technologies Proprietar Preparacion de complejos de platino (ii).
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
BRPI0708004A2 (pt) * 2006-01-30 2011-05-17 Platco Technologies Proprietary Ltd preparação de complexos de platina (ii)
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
US9265747B2 (en) 2008-08-26 2016-02-23 Massachusetts Institute Of Technology Platinum (IV) complexes for use in dual mode pharmaceutical therapy
EA201490067A1 (ru) 2011-06-21 2014-05-30 Массачусетс Инститьют Оф Текнолоджи Композиции и способы для лечения рака
WO2013033041A1 (en) 2011-08-26 2013-03-07 The Regents Of The University Of California Platinum anticancer agents
US9133225B2 (en) 2013-03-13 2015-09-15 Massachusetts Institute Of Technology Dual targeting anticancer agents
US9593139B2 (en) 2013-04-05 2017-03-14 Massachusetts Institute Of Technology Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
CN103360431B (zh) * 2013-07-16 2015-07-01 山西大学 一种以8-氨基喹哪啶为母体的金属配合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182943A1 (en) * 1972-04-10 1973-12-14 Rustenburg Platinum Mines Ltd Cis-dihalo-bis(ethyleneimine) platinum (ii) derivs - anti-cancer agents
JPS63264492A (ja) * 1986-12-18 1988-11-01 Shionogi & Co Ltd アンミン−脂環系アミン白金錯体および抗腫瘍剤
CA1327039C (en) * 1986-12-18 1994-02-15 Tetsushi Totani Ammine-alicyclic amine-platinum complexes and antitumor agents
US5026694A (en) * 1987-04-13 1991-06-25 The British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
US4921963A (en) * 1987-04-13 1990-05-01 British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
GB9502799D0 (en) 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
CA2497025A1 (en) * 2002-09-11 2004-03-25 Board Of Regents, The University Of Texas System Platinum complexes as antitumor agents in combination with biochemical modulation

Also Published As

Publication number Publication date
EP1420775A1 (de) 2004-05-26
CA2456348A1 (en) 2003-03-06
US7122668B2 (en) 2006-10-17
DE60235375D1 (de) 2010-04-01
US20050090478A1 (en) 2005-04-28
WO2003017998B1 (en) 2003-08-28
WO2003017998A1 (en) 2003-03-06
JP2005501859A (ja) 2005-01-20
EP1420775B1 (de) 2010-02-17
IL159993A0 (en) 2004-06-20
ES2339228T3 (es) 2010-05-18

Similar Documents

Publication Publication Date Title
ATE457992T1 (de) Platinkomplexe und deren verwendung in der therapie
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
TR200200795T2 (tr) 5-HT1B antagonistleri olarak piperazin türevleri
BG108660A (en) Pyrrolidinone derivatives
MY127718A (en) Dolastatin 10 derivatives.
DE69834269D1 (de) Piperidinylsubstituierte pyridylalkan-, -alken- und -alkincarbonsäuren als cytostatika und immunsuppressiva
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
ATE356130T1 (de) Inhibitoren von cruzipain und anderen cysteinproteasen
SE9703414D0 (sv) New compounds
ATE319718T1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
DK1379508T3 (da) N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
ATE333901T1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
ATE411984T1 (de) Neue kondensierte n-pyrazinyl-sulfonamide und deren verwendung bei der behandlung von chemokinvermittelten krankheiten
DE60103856D1 (de) Thiazolopyrimidine und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
BG105710A (en) 5ht1 antagonists for antidepressant therapy
TR199901570T2 (xx) N�rokinin antagonistleri olarak piperazin t�revleri
ATE408619T1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
ATE349210T1 (de) Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties